https://www.selleckchem.com/pr....oducts/Erlotinib-Hyd
The perception of KM and willingness to receive KM treatments were mediated by previous KM experiences. A higher accessibility towards KM treatments are necessary. © 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V.A 75-year-old male evaluated for pancytopenia. Abnormal lymphocytes with hairy projections noted on peripheral blood. Bone marrow examination showed diffuse proliferation of CD20+ B-lymphocytes. Flowcytometry revealed monoclonal lambda-restricted B-cells expressing CD19, CD20, CD1
Curtir
Comentario
Compartilhar
